Both in Medical Labs
GRAIL vs Celcuity
Over the past year GRAL returned +78.0% and CELC returned −5.1%; their daily moves had a correlation of 0.26.
GRAL +78.0% CELC −5.1%Growth of $1, one year, split-adjusted
| Metric | GRAL | CELC |
|---|---|---|
| Price | $143.66 | $69.24 |
| Market cap | $6.42B | $3.39B |
| Today | +3.03% | −0.69% |
| 1 month | +4.6% | −2.8% |
| 6 months | +128.9% | −50.3% |
| Year to date | +67.8% | −30.6% |
| 1 year | — | −7.9% |
| Revenue growth (YoY) | +25.7% | — |
| Gross margin | −28.1% | — |
| Net margin | −246.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 38.8× | — |
| Net cash | $861.6M | $809.0K |
| Dividend yield | — | — |
| Volatility (60d) | 96.8% | 53.6% |
| Short % of float | 19.3% | 25.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).